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Asthma is characterized by chronic airway inflammation with 
intense eosinophil and lymphocyte infiltration, mucus hyper-
production, and airway hyperresponsiveness. Accumulating 
evidence indicates that antigen-specific Th2 cells and their 
cytokines such as IL-4, IL-5, and IL-13 orchestrate these 
pathognomonic features of asthma. In addition, we and oth-
ers have recently shown that IL-17-producing CD4
＋ T cells 
(Th17 cells) and IL-23, an IL-12-related cytokine that is es-
sential for survival and functional maturation of Th17 cells, 
are involved in antigen-induced airway inflammation. In this 
review, our current understanding of the roles of IL-23 and 
Th17 cells in the pathogenesis of allergic airway inflamma-
tion will be summarized.
[Immune Network 2010;10(1):1-4]
INTRODUCTION
It is well established that there is a strong correlation between 
the presence of eosinophils and the presence of Th2 cells in 
the asthmatic airways and that classical Th2 cell-derived cyto-
kines, namely IL-4, IL-5, and IL-13, play critical roles in or-
chestrating and amplifying allergic inflammation in asthma. In 
addition, several lines of evidence suggest that Th17 cells and 
their cytokines such as IL-17A and IL-17F are involved in neu-
trophil recruitment in severe asthma. Moreover, we have re-
cently  shown  that  IL-23-Th17  cell  axis  enhances  Th2  cell- 
mediated eosinophilic airway inflammation. We will discuss 
the roles of IL-23 and Th17 cells in airway inflammation in 
asthma.
THE BASIS OF IL-23-Th17 CELL AXIS
The original member of IL-17 family cytokines, IL-17A, was 
reported  in  1995  and  subsequently  5  cytokines,  IL-17B, 
IL-17C, IL-17D, IL-17E (also known as IL-25), and IL-17F were 
identified as IL-17 family cytokines (1). IL-17 family cytokines 
are disulfide-linked homodimeric/heterodimeric proteins that 
possess a characteristic cystein knot structure (2). IL-17A and 
IL-17F  are  mainly  produced  by  a  recently  identified  sub-
population of CD4
＋ T cells, namely Th17 cells, which seem 
to  be  involved  in  the  pathogenesis  of  a  variety  of  auto-
immune diseases (3,4). IL-17A  and IL-17F  homodimers and 
IL-17F/IL-17A heterodimer transduce their signals through the 
receptor  composed  of  IL-17RA  and  IL17RC  (5,6).
  IL-23 has been identified as a novel IL-12 family cytokine 
which is composed of a p19 subunit specific for IL-23 and 
a p40 subunit shared with IL-12 (7). Despite a structural sim-
ilarity between IL-12 and IL-23, it is apparent that IL-23, rather 
than IL-12, plays pathogenic roles in chronic inflammation in 
a  number  of  disease  models,  including  experimental  auto-
immune  encephalomyelitis,  collagen-induced  arthritis,  psor-
iasis, and inflammatory bowel diseases (3,4). In addition, a 
recent study has revealed that IL-23 is crucial for the main-
tenance of Th17 cells (8). Moreover, McGeachy et al. have 
shown that IL-23 is required for full acquisition of an effector 
function  of  Th17  cells  (9).  These  findings  indicate  that 
IL-23-Th17 cell axis plays a key role in the development of 
inflammatory  diseases  including  autoimmune  diseases.Role of IL-23 and Th17 Cells in Airway Inflammation in Asthma
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ROLES OF IL-23-Th17 CELL AXIS IN NEUTROPHILIC 
INFLAMMATION IN THE AIRWAYS OF ASTHMA
While it  is  well established  that pathognomonic  features of 
asthma including intense eosinophilic infiltration, airway re-
modeling, and airway hyperresponsiveness (AHR) are medi-
ated by Th2 cytokines such as IL-4, IL-5, and IL-13 from anti-
gen-specific Th2 cells and inflammatory mediators from acti-
vated mast cells (10-12), several lines of evidence suggest that 
IL-17A and IL-17F are also involved in antigen-induced neu-
trophil infiltration in murine asthma models (13,14). It has al-
s o  b e e n  s h o w n  t h a t  I L - 1 7 A  i s  e xpressed  in  the  airways  of 
asthmatic patients and its expression is correlated with the se-
verity of asthma (15-17). IL-17A has also been shown to stim-
ulate bronchial fibroblasts, epithelial cells, and smooth muscle 
cells and induce the expression of a variety of cytokines and 
chemokines, which are important for granulopoiesis and neu-
trophil recruitment (18). The ability of IL-17A to evoke migra-
tion of neutrophils makes it likely that IL-17A is involved in 
severe asthma, of which neutrophil infiltration is one of the 
hallmarks (15-17). Moreover, it has recently been shown that 
Th17  cell-mediated  neutrophilic  airway  inflammation  is  ste-
roid-resistant (19). Furthermore, others and we have demon-
strated  that  IL-23  p19  mRNA  is  induced  upon  antigen  in-
halation  in  the  lung  of  antigen-sensitized  mice  (20,21).  We 
have also shown that the enforced expression of IL-23 in the 
lung or the transfer of antigen-specific Th17 cells enhances 
antigen-induced neutrophil recruitment into the airways (21). 
These findings suggest that IL-23-Th17 cell axis plays crucial 
roles in causing neutrophilic airway inflammation especially 
in severe asthma. Further studies identifying the cellular and 
molecular targets of IL-23-Th17 cell axis in the induction of 
neutrophilic airway inflammation could help us to develop a 
novel  therapeutic  approach  for  severe  asthma.
ROLES OF IL-23-Th17 CELL AXIS IN EOSINOPHILIC 
INFLAMMATION IN THE AIRWAYS OF ASTHMA
Recently, we have shown that the administration of anti-p19 
antibody,  which  neutralizes  the  bioactivity  of  IL-23  but  not 
of IL-12,  attenuates not  only  antigen-induced  neutrophil  re-
cruitment but also antigen-induced eosinophil recruitment in-
to the airways (21). The administration of anti-p19 antibody 
also  decreases  antigen-induced  Th2  cytokine  production  in 
the airways (21). In addition, Haworth et al. have shown that 
resolvin  E1,  an  endogenous  lipid  mediator,  inhibits  eosi-
nophhilic airway inflammation by suppressing the expression 
of IL-23 in the lung (22). Moreover, we have shown that en-
forced expression of IL-23 in the lung enhances not only anti-
gen-induced IL-17A production and neutrophil recruitment in 
the airways but also antigen-induced Th2 cytokine production 
and eosinophil recruitment in the airways (21). These find-
ings suggest a substantial role of IL-23 in causing eosinophilic 
inflammation  in  the  airways.
    The mechanism underlying IL-23-mediated enhancement of 
eosinophilic airway inflammation is still largely unknown. We 
have  shown  that  although  the  production  of  IL-17A  is  en-
hanced  by  the  enforced  expression  of  IL-23  in  the  lung, 
IL-23-mediated  enhancement  of  eosinophilic  airway  in-
flammation  is  still  observed  in  IL-17A-deficient  mice  (21). 
These results are consistent with previous findings that anti-
gen-induced eosinophilic airway inflammation is induced nor-
mally in IL-17A-deficient mice (23,24). In addition, it has been 
demonstrated  that  IL-17F-deficient  mice  exhibit  rather  ex-
acerbated  antigen-induced  eosinophilic  airway  inflammation 
(25).  These  findings  suggest  that  IL-23  enhances  anti-
gen-induced eosinophilic airway inflammation by the mecha-
nism independent of IL-17A and IL-17F. IL-22, an IL-10-relat-
ed  cytokine,  is  also  expressed  in  CD4
＋ T  c e l l s  u n d e r  
Th17-polarizing  conditions  and  mediates  IL-23-induced  der-
mal inflammation and hyperplasia of the epidermis in psor-
iasis (26). The role of IL-22 in IL-23-mediated enhancement 
of eosinophilic airway inflammation is under investigation in 
our  laboratory.
    We have also addressed the role of Th17 cells themselves 
in the induction of eosinophilic airway inflammation by adop-
tive transfer experiments (21). Although the transfer of anti-
gen-specific Th17 cells to non-sensitized mice does not pro-
voke antigen-induced eosinophil recruitment into the airways, 
co-transfer of antigen-specific Th17 cells with antigen-specific 
Th2 cells significantly enhances Th2 cell-mediated eosinophil 
recruitment into the airways (21). When antigen-specific Th17 
cells are transferred to antigen-sensitized mice in which en-
dogenous  antigen-specific  Th2  cells  are  present,  Th17  cells 
significantly enhance antigen-induced eosinophilic airway in-
flammation  (21).  Therefore,  it  is  indicated  that  Th17  cells 
themselves  do  not  induce  eosinophilic  airway  inflammation 
but enhance Th2 cell-mediated eosinophilic airway inflamma-
tion.
    Interestingly, co-transfer of Th17 cells with Th2 cells enhan-
ces the expression of eotaxin-1/eotaxin-2 in the lung (21). In 
addition, the neutralization of eotaxin-1/eotaxin-2 prior to the Role of IL-23 and Th17 Cells in Airway Inflammation in Asthma
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inhaled  antigen  challenge  decreases  the  eosinophil  recruit-
ment into the airways of the mice transferred with a combina-
tion of Th2 cells and Th17 cells (21). These findings suggest 
that Th17 cells may enhance eosinophilic airway inflamma-
tion by up-regulating the expression of eotaxin-1/eotaxin-2. 
In this regard, it has been demonstrated that STAT6 and NF-
κB  synergistically  induce  eotaxin  expression  in  fibroblasts 
and epithelial cells (27). Because Th17 cells produce TNF-α 
(8), which activates NF-κB pathways, it is plausible that the 
induction of eotaxin expression by the co-activation of Th2 
cells and Th17 cells is mediated by the synergistic effect of 
IL-4/IL-13-STAT6 pathway and TNF-α-NF-κB pathway. This 
notion is consistent with a recent report showing the efficacy 
of TNF-α neutralization by etanercept on severe asthma (28).
    Pathophysiological situations in which IL-23-Th17 cell axis 
plays  a  crucial  role  in  asthmatic  patients  remain  unclear. 
Importantly, it has been demonstrated that antigen-presenting 
cells including DCs produce IL-23 upon a variety of stimuli 
such as TNF-α, CD40L, LPS, and CpG-ODN. IL-23 is also in-
duced  in  the  lung  upon  viral  or  bacterial  infection.  Thus, 
IL-23-Th17 cell axis may be involved in the exacerbation of 
asthmatics by viral or bacterial infection. In addition, it has 
been  reported  that  the  engagement  of  Dectin-1  by  fungal 
component β-glucan activates DCs to produce IL-23 (29,30). 
Therefore, IL-23-Th17 cell axis may also be involved in im-
mune  responses  in  allergic  bronchopulmonary  aspergillosis 
(ABPA).
    In conclusion, IL-23 and Th17 cells are involved not only 
in causing antigen-induced neutrophil recruitment into the air-
ways but also in the enhancement of Th2 cell-mediated eosi-
nophil recruitment into the airways. Although further studies 
are required to address the molecular mechanisms of IL-23- 
and  Th17  cell-mediated  enhancement  of  allergic  airway  in-
flammation, our results raise the possibility that IL-23 and/or 
Th17  cells  could  be  a  novel  therapeutic  target  for  severe 
asthma.
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